Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29149768.
- Also identified by DOI 10.1002/ana.25099.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In Parkinson disease (PD), mitochondrial dysfunction associates with nigral dopaminergic neuronal loss. Cholinergic neuronal loss co-occurs, particularly within a brainstem structure, the pedunculopontine nucleus (PPN). We isolated single cholinergic neurons from postmortem PPNs of aged controls and PD patients. Mitochondrial DNA (mtDNA) copy number and mtDNA deletions were increased significantly in PD patients compared to controls. Furthermore, compared to controls the PD patients had significantly more PPN cholinergic neurons containing mtDNA deletion levels exceeding 60%, a level associated with deleterious effects on oxidative phosphorylation. The current results differ from studies reporting mtDNA depletion in nigral dopaminergic neurons of PD patients. Ann Neurol 2017;82:1016-1021.
Medical subject headings
- Cholinergic Neurons
- DNA, Mitochondrial
- Parkinson Disease
- Pedunculopontine Tegmental Nucleus